U.S. Could Have 100 Million COVID-19 Vaccine Doses by 2021

Author:
Publish date:
Video Duration:
1:48

Good morning, it’s Wednesday, June 3. 

Worldwide, there are 6.4 million cases of the coronavirus, with over 380,000 deaths.

The U.S. has over 1.8 million cases of the virus, with over 106,000 deaths per data from Johns Hopkins.

Brazil has 555,000 cases and 31,000 deaths.

Ahead of the opening bell, investors again are shaking off mass protests and riots across the United States following the killing of George Floyd by Minneapolis police officers last week and testy relations between Washington and Beijing that some fear could derail the trade agreement between the world's two largest economies.

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases and a prominent figure in the U.S.’s fight against the coronavirus, said that the U.S. should have around 100 million doses of one candidate COVID-19 vaccine by the beginning of 2021 in an interview with the Journal of the American Medical Association.

Fauci also said that Moderna’s vaccine candidate should go into the final stages of trials--A.K.A Phase III--by mid-summer.

He said, “The real business end of this all will be the Phase III that starts in the first week of July, hopefully...We want to get as many data points as we can.”

The final stage will include around 30,000 people between the ages of 18 and 55, and some elderly as well as people with underlying health conditions, both groups who are particularly impacted by the coronavirus.

Fauci did note that the plan is to manufacture vaccine doses before it’s even clear whether or not the vaccine works, so that--if the vaccine does work--it can be handed out quickly. That means manufacturing around 100 million doses.

You can follow Katherine Ross on Twitter at @byKatherineRoss.

Read more from Katherine Ross here.

Watch More of the Latest Videos on TheStreet and Jim Cramer